Recherche avancée
Affichage des résultats 2441 à 2460 sur 8584 au total
-
Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Interactions and Resolve Medication Issues More Effectively?
Fanny Moreau, Nicolas Simon, Julia Walther, Mathilde Dambrine, Gaëtan Kosmalski, Stéphanie Genay, Maxime Perez, Dominique Lecoutre, Stéphanie Belaiche, Chloé Rousselière, Michel Tod, Bertrand Décaudin, Pascal Odou
-
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients
A. L. Bienvenu, P. Pradat, A. Plesa, V. Leclerc, V. Piriou, J. L. Fellahi, L. Argaud, T. Rimmele, J. Menotti, F. Aubrun, J. C. Richard, M. C. Gagnieu, F. Parant, C. Chidiac, G. Leboucher, M. Tod, S. Goutelle
-
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)
Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, Gaëtan De Rauglaudre, Florence Joly, Annick Chevalier-Place, Pierre Combe, Alain Lortholary, Salima Hamizi, Nadia Raban, Gwénaël Ferron, Jérôme Meunier, Dominique Berton-Rigaud, Jérôme Alexandre, Marie-Christine Kaminsky, Coraline Dubot, Alexandra Leary, Emmanuelle Malaurie, Benoit You
-
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments
Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens, Elisabeth Polard, Béatrice Saint-Salvi, Agnés Sommet, Michel Tod, Chantal Barin-Le-Guellec
-
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria
Yobouet Ines Kouakou, Michel Tod, Gilles Leboucher, Adeline Lavoignat, Guillaume Bonnot, Anne-Lise Bienvenu, Stephane Picot
-
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies
Pauline Corbaux, Mévidette El-Madani, Michel Tod, Julien Péron, Denis Maillet, Jonathan Lopez, Gilles Freyer, Benoit You
-
Thesaurus for off-label indications for systemic antifungal agents
A.L. Bienvenu, M. Aussedat, F. Maldonado, R. Kavafian, C. Barbieri, M. Tod, C. Paillet, L. Juillard, C. Chidiac, G. Leboucher
-
Respiratory depression related to multiple drug–drug interactions precipitated by a fluconazole loading dose in a patient treated with oxycodone
Bruno Charpiat, Michel Tod, Benjamin Darnis, Guillaume Boulay, Marie-Claude Gagnieu, Jean‐yves Mabrut
-
Identification des lacunes de connaissances des étudiants en filière officine débutant le stage de 5e année
B. Charpiat, S. Derfoufi, M. Larger, A. Janoly-Dumenil, C. Mouchoux, B. Allenet, M. Tod, J. Grassin, R. Boulieu, O. Catala, P. Bedouch, Joëlle Goudable, C. Vinciguerra
-
Identification des lacunes de connaissances des étudiants en filière officine débutant le stage de 5e année : propositions pour modifier le contenu de l’enseignement
B. Charpiat, S. Derfoufi, M. Larger, A. Janoly-Dumenil, C. Mouchoux, Benoit Allenet, M. Tod, J. Grassin, R. Boulieu, O. Catala, P. Bedouch, Joëlle Goudable, C. Vinciguerra
-
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases
Charry F. De, O. Colomban, Benoit You, A. Ruffion, P. Paparel, M. Wilbaux, M. Tod, G. Freyer, P. Perrin
-
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial
Olivier Lortholary, Caroline Roussillon, Céline Boucherie, Christophe Padoin, Marie-Laure Chaix, Guillaume Breton, Agathe Rami, Nicolas Veziris, Olivier Patey, Eric Caumes, Thierry May, Jean-Michel Molina, Jérôme Robert, Michel Tod, Catherine Fagard, Geneviève Chêne
-
How to solve the problem of spontaneous bacterial clearance when testing new antibiotic treatment: results on experimental pneumonia due to a derepressed cephalosporinase-producing Enterobacter cloacae
Anne Jacolot, Claire Judel, Kamel Louchahi, Michel Tod, Sandrine Marchand, Olivier Petitjean, Olivier Mimoz
-
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.
Floriane Lignet, Sébastien Benzekry, Shelby Wilson, Frédérique Billy, Olivier Saut, Michel Tod, Benoit You, A. Adda Berkane, S. Kassour, M. X. Wei, Emmanuel Grenier, Benjamin Ribba
-
Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.
Tristan Ferry, Agathe Sénéchal, Marie-Claude Gagnieu, André Boibieux, Frédéric Laurent, Thomas Perpoint, Michel Tod, Christian Chidiac
-
A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy.
Benjamin Ribba, Gentian Kaloshi, Mathieu Peyre, Damien Ricard, Vincent Calvez, Michel Tod, Branka Cajavec-Bernard, Ahmed Idbaih, Dimitri Psimaras, Linda Dainese, Johan Pallud, Stéphanie Cartalat-Carel, Jean-Yves Delattre, Jérôme Honnorat, Emmanuel Grenier, François Ducray
-
Prédiction quantitative des interactions médicamenteuses impliquant les cytochromes 3A4 et 2D6 : approche in vivo
Sylvain Goutelle, M. Tod
-
A pharmacodynamic model of ganciclovir antiviral effect and toxicity for lymphoblastoid cells suggests a new dosing regimen to treat cytomegalovirus infection
A. Janoly-Dumenil, I. Rouvet, Nathalie Bleyzac, F. Morfin, Mt. Zabot, M. Tod
-
A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During Induction Therapy
Dr Verstuyft, Xavier Delavenne, Alexandra Rousseau, Annie Robert, Michel Tod, Bertrand Diquet, Martine Lebot, Patrice Jaillon, Laurent Becquemont
-
Model-based design of rituximab dosing optimization in follicular non-hodgkin lymphoma
David Ternant, Guillaume Cartron, E. Henin, Michel Tod, Pascal Girard, Gilles Paintaud